Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Follow-on Offering |
Follow-on Offering
Common Stock
|
Follow-on Offering
Additional Paid-In Capital
|
At-the-Market Equity Offering |
At-the-Market Equity Offering
Common Stock
|
At-the-Market Equity Offering
Additional Paid-In Capital
|
Private Placement Offering 1 |
Private Placement Offering 1
Common Stock
|
Private Placement Offering 1
Additional Paid-In Capital
|
Private Placement Offering 2 |
Private Placement Offering 2
Common Stock
|
Private Placement Offering 2
Additional Paid-In Capital
|
Private Placement Offering 3 |
Private Placement Offering 3
Common Stock
|
Private Placement Offering 3
Additional Paid-In Capital
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2022 | $ 8,507,793 | $ 1,096 | $ 52,729,942 | $ (44,207,272) | $ (15,973) | |||||||||||||||
Balance, Shares at Dec. 31, 2022 | 10,955,904 | |||||||||||||||||||
Issuance of restricted stock | 164,070 | $ 4 | 164,066 | |||||||||||||||||
Issuance of restricted stock, Shares | 40,500 | |||||||||||||||||||
Stock-based compensation expense | 537,522 | 537,522 | ||||||||||||||||||
Foreign currency translation adjustment | (9,301) | (9,301) | ||||||||||||||||||
Net loss | (4,116,876) | (4,116,876) | ||||||||||||||||||
Balance at Mar. 31, 2023 | 5,083,208 | $ 1,100 | 53,431,530 | (48,324,148) | (25,274) | |||||||||||||||
Balance, Shares at Mar. 31, 2023 | 10,996,404 | |||||||||||||||||||
Balance at Dec. 31, 2022 | 8,507,793 | $ 1,096 | 52,729,942 | (44,207,272) | (15,973) | |||||||||||||||
Balance, Shares at Dec. 31, 2022 | 10,955,904 | |||||||||||||||||||
Net loss | (8,640,500) | |||||||||||||||||||
Balance at Jun. 30, 2023 | 6,874,334 | $ 1,365 | 59,746,649 | (52,847,772) | (25,908) | |||||||||||||||
Balance, Shares at Jun. 30, 2023 | 13,648,425 | |||||||||||||||||||
Balance at Mar. 31, 2023 | 5,083,208 | $ 1,100 | 53,431,530 | (48,324,148) | (25,274) | |||||||||||||||
Balance, Shares at Mar. 31, 2023 | 10,996,404 | |||||||||||||||||||
Issuance of restricted stock | 324,260 | $ 9 | 324,251 | |||||||||||||||||
Issuance of restricted stock, Shares | 96,521 | |||||||||||||||||||
Issuance of warrants to underwriter in connection with follow-on offering | 241,109 | 241,109 | ||||||||||||||||||
Issuance of common shares | $ 4,156,859 | $ 256 | $ 4,156,603 | |||||||||||||||||
Issuance of common shares, Shares | 2,555,500 | |||||||||||||||||||
Stock-based compensation expense | 618,932 | 618,932 | ||||||||||||||||||
Issuance of stock options to satisfy accrued bonus | 974,224 | 974,224 | ||||||||||||||||||
Foreign currency translation adjustment | (634) | (634) | ||||||||||||||||||
Net loss | (4,523,624) | (4,523,624) | ||||||||||||||||||
Balance at Jun. 30, 2023 | 6,874,334 | $ 1,365 | 59,746,649 | (52,847,772) | (25,908) | |||||||||||||||
Balance, Shares at Jun. 30, 2023 | 13,648,425 | |||||||||||||||||||
Balance at Dec. 31, 2023 | 477,511 | $ 1,699 | 64,472,249 | (63,980,177) | (16,260) | |||||||||||||||
Balance, Shares at Dec. 31, 2023 | 16,986,254 | |||||||||||||||||||
Issuance of restricted stock | 11,500 | $ 1 | 11,499 | |||||||||||||||||
Issuance of restricted stock, Shares | 12,500 | |||||||||||||||||||
Issuance of common shares | $ 565,623 | $ 51 | $ 565,572 | $ 590,411 | $ 250 | $ 590,161 | $ 90,618 | $ 58 | $ 90,560 | |||||||||||
Issuance of common shares, Shares | 507,754 | 2,496,318 | 578,643 | |||||||||||||||||
Stock-based compensation expense | 349,965 | 349,965 | ||||||||||||||||||
Issuance of warrants in connection | $ 230,685 | $ 230,685 | ||||||||||||||||||
Foreign currency translation adjustment | (13,786) | (13,786) | ||||||||||||||||||
Net loss | (8,067,455) | (8,067,455) | ||||||||||||||||||
Balance at Mar. 31, 2024 | (5,764,928) | $ 2,059 | 66,310,691 | (72,047,632) | (30,046) | |||||||||||||||
Balance, Shares at Mar. 31, 2024 | 20,581,469 | |||||||||||||||||||
Balance at Dec. 31, 2023 | $ 477,511 | $ 1,699 | 64,472,249 | (63,980,177) | (16,260) | |||||||||||||||
Balance, Shares at Dec. 31, 2023 | 16,986,254 | |||||||||||||||||||
Exercise of stock options, shares | 101,837 | |||||||||||||||||||
Net loss | $ (16,946,731) | |||||||||||||||||||
Balance at Jun. 30, 2024 | 3,161,895 | $ 2,374 | 84,108,607 | (80,926,908) | (22,178) | |||||||||||||||
Balance, Shares at Jun. 30, 2024 | 23,737,833 | |||||||||||||||||||
Balance at Mar. 31, 2024 | (5,764,928) | $ 2,059 | 66,310,691 | (72,047,632) | (30,046) | |||||||||||||||
Balance, Shares at Mar. 31, 2024 | 20,581,469 | |||||||||||||||||||
Exercise of stock options | 185,646 | $ 10 | 185,636 | |||||||||||||||||
Exercise of stock options, shares | 101,837 | |||||||||||||||||||
Issuance of common shares | $ 6,801,664 | $ 202 | $ 6,801,462 | $ 162,077 | $ 49 | $ 162,028 | ||||||||||||||
Issuance of common shares, Shares | 2,015,122 | 494,096 | ||||||||||||||||||
Stock-based compensation expense | 413,948 | 413,948 | ||||||||||||||||||
Issuance of warrants in connection | $ 172,925 | $ 172,925 | ||||||||||||||||||
Exercise of warrants, shares | 545,309 | |||||||||||||||||||
Exercise of warrants | 3,191,675 | $ 54 | 3,191,621 | |||||||||||||||||
Reclassification of liability classified warrants to equity | 6,870,296 | 6,870,296 | ||||||||||||||||||
Foreign currency translation adjustment | 7,868 | 7,868 | ||||||||||||||||||
Net loss | (8,879,276) | (8,879,276) | ||||||||||||||||||
Balance at Jun. 30, 2024 | $ 3,161,895 | $ 2,374 | $ 84,108,607 | $ (80,926,908) | $ (22,178) | |||||||||||||||
Balance, Shares at Jun. 30, 2024 | 23,737,833 |